Ingenol mebutate treatment for actinic cheilitis: clinical, histopathological and p53 profile of 14 cases

Ingenol mebutate treatment for actinic cheilitis: clinical, histopathological and p53 profile of 14 cases

Introduction Actinic cheilitis (AC) is part of a spectral disease of keratinocyte carcinomas considered by some authors an early stage of in situ squamous cell carcinoma. Treatment options for AC can be lesion and field-directed therapies. Ingenol mebutate (IM) induces rapid and direct cell death an...

Full description

Bibliographic Details
Main Authors: Rita de Cassia Rossini, Gerson Dellatorre, Lismary Aparecida de Forville Mesquita, Roberto Gomes Tarlé
Format: Article
Language:English
Published: Taylor & Francis Group 2021-11-01
Series:Journal of Dermatological Treatment
Subjects:
actinic cheilitis
ingenol mebutate
precancerous conditions
tumor suppressor protein p53
Online Access:http://dx.doi.org/10.1080/09546634.2020.1724865

Internet

http://dx.doi.org/10.1080/09546634.2020.1724865

Similar Items